您的当前位置:首页 > 行业数据 > AK104治疗末线宫颈癌对比其他国内外指南优先推荐疗法在全人群展现较好的疗效风险比
图片属性
图片格式:PNG 图片大小:305KB 图片尺寸:2304*1446
同报告图片
 / 4
AK104治疗末线宫颈癌对比其他国内外指南优先推荐疗法在全人群展现较好的疗效风险比_第1页
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
AK104治疗末线宫颈癌对比其他国内外指南优先推荐疗法在全人群展现较好的疗效风险比_第2页
fCDlk4HniYwgICAgICAgfCDljaDmr5QgIHwKfC0tLS0tLS0tLS0tLXwtLS0tLS18CnwgQkFJIFpFIEFOICB8IDM1JSAgfAp8IFRZVllUICAgICAgfCAyNSUgIHwKfCBBTCBSVUkgS0EgIHwgMTUlICB8CnwgS0VZVFJVREEgICB8IDEwJSAgfAp8IFRVTyBZSSAgICAgfCA1JSAgIHwKfCBIQU4gU0hJIFpIVUFORyB8IDMlICB8CnwgVEVDRU5UUklRICB8IDIlICAgfAp8IE9QRElWTyAgICAgfCAyJSAgIHwKfCBBTiBOSSBLRSAgIHwgMSUgICB8CnwgRU4gV0VJIERBICB8IDElICAgfAp8IE9USEVSUyAgICAgfCAxJSAgIHwKCui1hOaWmeadpea6kO+8mklRVklB77yM5Lit5rOw6K+B5Yi456CU56m25omA
AK104治疗末线宫颈癌对比其他国内外指南优先推荐疗法在全人群展现较好的疗效风险比_第3页
AK104治疗末线宫颈癌对比其他国内外指南优先推荐疗法在全人群展现较好的疗效风险比_第4页
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
AK104治疗末线宫颈癌对比其他国内外指南优先推荐疗法在全人群展现较好的疗效风险比_第5页
所属报告: 康方生物-港股公司研究报告-双特异抗体龙头国际化之路现胜利曙光-240621(37页).pdf
打包全文图表

相关数据

客服
商务合作
小程序
服务号
折叠